These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 26002728)

  • 1. Anti-Inflammatory Effects of Resveratrol in Patients with Ulcerative Colitis: A Randomized, Double-Blind, Placebo-controlled Pilot Study.
    Samsami-Kor M; Daryani NE; Asl PR; Hekmatdoost A
    Arch Med Res; 2015 May; 46(4):280-5. PubMed ID: 26002728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resveratrol Supplementation and Oxidative/Anti-Oxidative Status in Patients with Ulcerative Colitis: A Randomized, Double-Blind, Placebo-controlled Pilot Study.
    Samsamikor M; Daryani NE; Asl PR; Hekmatdoost A
    Arch Med Res; 2016 May; 47(4):304-9. PubMed ID: 27664491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammatory biomarkers response to two dosages of vitamin D supplementation in patients with ulcerative colitis: A randomized, double-blind, placebo-controlled pilot study.
    Karimi S; Tabataba-Vakili S; Ebrahimi-Daryani N; Yari Z; Karimi A; Hedayati M; Hekmatdoost A
    Clin Nutr ESPEN; 2020 Apr; 36():76-81. PubMed ID: 32220372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of two vitamin D regimens on ulcerative colitis activity index, quality of life and oxidant/anti-oxidant status.
    Karimi S; Tabataba-Vakili S; Yari Z; Alborzi F; Hedayati M; Ebrahimi-Daryani N; Hekmatdoost A
    Nutr J; 2019 Mar; 18(1):16. PubMed ID: 30871542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of Nigella sativa on quality of life, disease activity index, and some of inflammatory and oxidative stress factors in patients with ulcerative colitis.
    Nikkhah-Bodaghi M; Darabi Z; Agah S; Hekmatdoost A
    Phytother Res; 2019 Apr; 33(4):1027-1032. PubMed ID: 30666747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subcutaneous golimumab induces clinical response and remission in patients with moderate-to-severe ulcerative colitis.
    Sandborn WJ; Feagan BG; Marano C; Zhang H; Strauss R; Johanns J; Adedokun OJ; Guzzo C; Colombel JF; Reinisch W; Gibson PR; Collins J; Järnerot G; Hibi T; Rutgeerts P;
    Gastroenterology; 2014 Jan; 146(1):85-95; quiz e14-5. PubMed ID: 23735746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A review of infliximab use in ulcerative colitis.
    Wilhelm SM; McKenney KA; Rivait KN; Kale-Pradhan PB
    Clin Ther; 2008 Feb; 30(2):223-30. PubMed ID: 18343261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resveratrol supplementation improves inflammatory biomarkers in patients with nonalcoholic fatty liver disease.
    Faghihzadeh F; Adibi P; Rafiei R; Hekmatdoost A
    Nutr Res; 2014 Oct; 34(10):837-43. PubMed ID: 25311610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Resveratrol Supplementation in Nrf2 and NF-κB Expressions in Nondialyzed Chronic Kidney Disease Patients: A Randomized, Double-Blind, Placebo-Controlled, Crossover Clinical Trial.
    Saldanha JF; Leal VO; Rizzetto F; Grimmer GH; Ribeiro-Alves M; Daleprane JB; Carraro-Eduardo JC; Mafra D
    J Ren Nutr; 2016 Nov; 26(6):401-406. PubMed ID: 27523436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of curcumin supplementation on clinical outcomes and inflammatory markers in patients with ulcerative colitis.
    Sadeghi N; Mansoori A; Shayesteh A; Hashemi SJ
    Phytother Res; 2020 May; 34(5):1123-1133. PubMed ID: 31802559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-inflammatory and antioxidant effects of resveratrol in healthy smokers a randomized, double-blind, placebo-controlled, cross-over trial.
    Bo S; Ciccone G; Castiglione A; Gambino R; De Michieli F; Villois P; Durazzo M; Cavallo-Perin P; Cassader M
    Curr Med Chem; 2013; 20(10):1323-31. PubMed ID: 23298135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized controlled trial on the coloprotective effect of coenzyme Q10 on immune-inflammatory cytokines, oxidative status, antimicrobial peptides, and microRNA-146a expression in patients with mild-to-moderate ulcerative colitis.
    Farsi F; Ebrahimi-Daryani N; Golab F; Akbari A; Janani L; Karimi MY; Irandoost P; Alamdari NM; Agah S; Vafa M
    Eur J Nutr; 2021 Sep; 60(6):3397-3410. PubMed ID: 33620550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Cis-palmitoleic acid supplementation on inflammation and expression of HNF4γ, HNF4α and IL6 in patients with ulcerative colitis.
    Bueno-Hernández N; Sixtos-Alonso MS; Milke García MDP; Yamamoto-Furusho JK
    Minerva Gastroenterol Dietol; 2017 Sep; 63(3):257-263. PubMed ID: 28185444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of short-chain fatty acid-butyrate supplementation on expression of circadian-clock genes, sleep quality, and inflammation in patients with active ulcerative colitis: a double-blind randomized controlled trial.
    Firoozi D; Masoumi SJ; Mohammad-Kazem Hosseini Asl S; Labbe A; Razeghian-Jahromi I; Fararouei M; Lankarani KB; Dara M
    Lipids Health Dis; 2024 Jul; 23(1):216. PubMed ID: 39003477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resveratrol supplementation decreases blood glucose without changing the circulating CD14
    Khodabandehloo H; Seyyedebrahimi S; Esfahani EN; Razi F; Meshkani R
    Nutr Res; 2018 Jun; 54():40-51. PubMed ID: 29914666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction with NCB-02 (curcumin) enema for mild-to-moderate distal ulcerative colitis - a randomized, placebo-controlled, pilot study.
    Singla V; Pratap Mouli V; Garg SK; Rai T; Choudhury BN; Verma P; Deb R; Tiwari V; Rohatgi S; Dhingra R; Kedia S; Sharma PK; Makharia G; Ahuja V
    J Crohns Colitis; 2014 Mar; 8(3):208-14. PubMed ID: 24011514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adalimumab therapy is associated with reduced risk of hospitalization in patients with ulcerative colitis.
    Feagan BG; Sandborn WJ; Lazar A; Thakkar RB; Huang B; Reilly N; Chen N; Yang M; Skup M; Mulani P; Chao J
    Gastroenterology; 2014 Jan; 146(1):110-118.e3. PubMed ID: 24067881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zingiber officinale and oxidative stress in patients with ulcerative colitis: A randomized, placebo-controlled, clinical trial.
    Nikkhah-Bodaghi M; Maleki I; Agah S; Hekmatdoost A
    Complement Ther Med; 2019 Apr; 43():1-6. PubMed ID: 30935515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ginger in patients with active ulcerative colitis: a study protocol for a randomized controlled trial.
    Shayesteh F; Haidari F; Shayesteh AA; Mohammadi-Asl J; Ahmadi-Angali K
    Trials; 2020 Mar; 21(1):278. PubMed ID: 32183895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of resveratrol supplementation on cardiovascular risk factors in patients with non-alcoholic fatty liver disease: a randomised, double-blind, placebo-controlled study.
    Faghihzadeh F; Adibi P; Hekmatdoost A
    Br J Nutr; 2015 Sep; 114(5):796-803. PubMed ID: 26234526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.